Virologic and immunologic outcomes of HIV-infected Ugandan children randomized to lopinavir-ritonavir or nonnucleoside-reverse-transcriptase-inhibitor therapy

BACKGROUND: In the PROMOTE-pediatrics trial, HIV-infected Ugandan children randomized to receive lopinavir-ritonavir (LPV/r)-based antiretroviral therapy (ART) experienced a lower incidence of malaria compared to children receiving non-nucleoside-reverse-transcriptase-inhibitor (NNRTI)-based-ART. He...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: RUEL, Theodore, KAKURU, Abel, IKILEZI, Gloria, MWANGWA, Florence, DORSEY, Grant, ROSENTHAL, Philip, CHARLEBOIS, Edwin, HAVLIR, Diane, KAMYA, Moses, ACHAN, Jane
Формат: Artigo
Язык:Inglês
Опубликовано: 2014
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3999287/
https://ncbi.nlm.nih.gov/pubmed/24326597
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAI.0000000000000071
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы